Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

Bibliografische Daten

OriginalspracheEnglisch
ISSN0887-6924
DOIs
StatusVeröffentlicht - 09.2022
PubMed 35790817